Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
This study seeks to show that it’s possible to reverse both Rheumatoid Arthritis (RA) and Psoriasis by integrating ... Project IMPACT: Discovering the best way to manage autoimmune conditions Project ...
Some 40 knee arthritis sufferers have undergone the treatment, called genicular arterial embolisation ... While it doesn't work for everyone, it offers a hopeful and exciting new option.' 'The ...
Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced its participation at the American College of Rheumatology (ACR) Convergence 2024, taking place in ...